Erdafitinib
Erdafitinib Brand Name– BALVERSA What is Erdafitinib Erdafitinib is a kinase inhibitor that inhibits FGFR1, FGFR2, FGFR3, and FGFR4. It is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma that has susceptible FGFR3 or FGFR2 genetic alterations and progressed during or following at least 1 line of platinum-containing chemotherapy …
